With enormous sums of capital managed in the UK, its managers seek optimal scientific-based investments to not only progress health and medicine but also generate what they hope to become huge returns . The bio-pharma industry, including the supporting clinical research sector, has considerable influence on the economy of the United Kingdom and economic, social and political ties to the Conservative Party in that nation. Back in 2010 when David Cameron came into power, boosted by a number of research and development initiatives and policies, now the UK has solidified its position as a global hub for biomedical research in part due to the sprawling National Health Service (NHS), a socialized health service, role as backer and supporter of research across the land. Last month, the UK Bioindustry Association authored a report declaring that a record $3.9 billion in equity financing went into the life science research sector.
UK Life Sciences Hub
That report revealed that the COVID-19 pandemic actually boosted the sector with investment rising from £1.8 billion ($2.5 billion) in 2019 to £2.8 billion ($3.9 billion) in 2020. That’s right, COVID-19 led to a record investment year ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).